These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

333 related items for PubMed ID: 349096

  • 1. Differences between cephalothin and newer parenterally absorbed cephalosporins in vitro: a justification for separate disks.
    Washington JA II.
    J Infect Dis; 1978 May; 137 Suppl():S32-S37. PubMed ID: 349096
    [Abstract] [Full Text] [Related]

  • 2. In vitro studies of cefamandole.
    Bodey GP, Weaver S.
    Antimicrob Agents Chemother; 1976 Mar; 9(3):452-7. PubMed ID: 769679
    [Abstract] [Full Text] [Related]

  • 3. In vitro susceptibility of cephalothin-resistant Enterobacteriaceae to cefoxitin and BL-S786.
    Meyer RD.
    J Antibiot (Tokyo); 1977 Apr; 30(4):326-9. PubMed ID: 324961
    [Abstract] [Full Text] [Related]

  • 4. A comparative study of the activity of cefamandole and other cephalosporins and analysis of the beta-lactamase stability and synergy of cefamandole with aminoglycosides.
    Fu KP, Neu HC.
    J Infect Dis; 1978 May; 137 Suppl():S38-S50. PubMed ID: 349097
    [Abstract] [Full Text] [Related]

  • 5. In-vitro activities of cefamandole and cephalothin against 1,881 clinical isolates. A multi-center study.
    Barry AL, Schoenknect FD, Shadomy S, Sherris JC, Thornsberry C, Washington JA, Kammer RB.
    Am J Clin Pathol; 1979 Nov; 72(5):858-60. PubMed ID: 506998
    [Abstract] [Full Text] [Related]

  • 6. The in vitro spectrum of the cephalosporins.
    Washington JA.
    Mayo Clin Proc; 1976 Apr; 51(4):237-50. PubMed ID: 1263595
    [Abstract] [Full Text] [Related]

  • 7. Susceptibility of cephalothin-resistant gram-negative bacilli to piperacillin, cefuroxime, and other selected antibiotics.
    George WL, Lewis RP, Meyer RD.
    Antimicrob Agents Chemother; 1978 Mar; 13(3):484-9. PubMed ID: 122524
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. [Antibacterial activity of cefotaxim in comparison with seven cephalosporins].
    Braveny I, Dickert H, Machka K.
    Infection; 1979 Mar; 7(5):231-6. PubMed ID: 389804
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. In vitro antibacterial activity of a new 1-oxa cephalosporin compound.
    Downs JT, Andriole VT.
    Yale J Biol Med; 1980 Mar; 53(2):149-59. PubMed ID: 6446810
    [Abstract] [Full Text] [Related]

  • 17. In vitro activity of ciprofloxacin compared with other agents against recent hospital isolates.
    Rubinstein E, Mark Z, Samra Y, Alkan M, Berger S.
    Chemioterapia; 1986 Apr; 5(2):75-82. PubMed ID: 2939966
    [Abstract] [Full Text] [Related]

  • 18. [In vitro testing of newer cephalosporins (author's transl)].
    Linzenmeier G, Rosenthal E.
    Infection; 1979 Apr; 7 Suppl 2():S225-7. PubMed ID: 437897
    [Abstract] [Full Text] [Related]

  • 19. Drug susceptibility-resistance pattern of gram-negative uropathogens to seven cephalosporins.
    Seneca H.
    Am J Med Sci; 1973 Nov; 266(5):381-5. PubMed ID: 4202701
    [No Abstract] [Full Text] [Related]

  • 20. [In vitro examination on antibacterial activities of broad-spectrum antibiotics against gram-negative clinical isolates (author's transl)].
    Deguchi K, Oda S, Sato Y, Ikeda Y, Nakamura T.
    Jpn J Antibiot; 1975 Dec; 28(6):785-94. PubMed ID: 1104913
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.